Re: Effect of carvedilol on plasma adiponectin concentration in patients with chronic heart failure.
Lou
Yu-Feng
YF
Shi
Xin-Ping
XP
Tong
Hui
H
Yu
Guo-You
GY
Yao
Geng-Dong
GD
Dong
Kan
K
D052242:Adiponectin / Q000097:blood; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D002227:Carbazoles / Q000627:therapeutic use*; D000077261:Carvedilol; D002908:Chronic Disease; D006333:Heart Failure / Q000097:blood / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D011412:Propanolamines / Q000627:therapeutic use*; D013318:Stroke Volume / Q000187:drug effects; D016896:Treatment Outcome; D016277:Ventricular Function, Left / Q000187:drug effects
C499918:ADIPOQ protein, human; D052242:Adiponectin; D000319:Adrenergic beta-Antagonists; D015415:Biomarkers; D002227:Carbazoles; D011412:Propanolamines; D000077261:Carvedilol